Acetyl tetrapeptide-5 is a synthetic four-unit peptide used as a cosmetic ingredient, sold by Lubrizol under the trade name Eyeseryl. This guide covers its structure, the claims made for it, the limited published research and its regulatory status. Sources were checked on November 17, 2026.
Quick answer: Acetyl tetrapeptide-5 (Eyeseryl) is a small lab-made peptide marketed for the under-eye area. Its manufacturer reports laboratory effects on glycation and vessel leakiness, but those data are not published in peer-reviewed form. It is a cosmetic ingredient, not a drug, and we found no Cosmetic Ingredient Review safety assessment for it.
Vitrapep does not sell acetyl tetrapeptide-5; this page is a reference summary of published research and regulatory information.
What is acetyl tetrapeptide-5?
Acetyl tetrapeptide-5 is an INCI name, the standard name used on cosmetic ingredient lists. CosIng, the European Commission’s cosmetic ingredient database, describes it as the “product obtained by the acetylation of Tetrapeptide-5” (CosIng, 2026). Acetylation adds an acetyl group to the start of the chain.
PubChem gives the structure as N-acetyl-β-alanyl-L-histidyl-L-seryl-L-histidine, or Ac-β-Ala-His-Ser-His-OH. It lists the formula as C20H28N8O7 and the molecular weight as 492.5 g/mol (PubChem CID 11620163). The first unit is beta-alanine, an amino acid not used to build proteins. The others are histidine, serine and histidine.
The first two units, beta-alanine and histidine, are the same pair that forms the natural dipeptide carnosine (Boldyrev et al., 2013). Our carnosine guide covers that molecule. For background on peptide naming and size, see our peptide primer.
PubChem lists Eyeseryl among the synonyms for this compound. Lubrizol sells Eyeseryl peptide and gives the INCI listing of its solution as glycerin, water and acetyl tetrapeptide-5 (Lubrizol). Lubrizol’s 2026 product Eyeseryl All In is described as a hexapeptide, so it is a different molecule (Lubrizol, 2026).
Acetyl tetrapeptide-5: key facts
| Fact | Detail |
|---|---|
| INCI name | Acetyl Tetrapeptide-5 |
| Structure type | Linear synthetic peptide; four units with an acetylated start and a free acid end |
| Sequence | Ac-β-Ala-His-Ser-His-OH |
| Molecular formula | C20H28N8O7 |
| Molecular weight | 492.5 g/mol |
| Main cosmetic function (CosIng) | Humectant |
| Trade name(s) | Eyeseryl (Lubrizol) |
How does acetyl tetrapeptide-5 work?
No peer-reviewed study we found explains a mechanism for acetyl tetrapeptide-5 in skin. The proposed mechanism comes from its manufacturer. Lubrizol states that it “helps inhibit glycation, vascular permeability and lipid accumulation, as showed in vitro” (Lubrizol).
Glycation is a reaction in which sugars bind to proteins and form damaged products. Vascular permeability is how easily fluid leaks from small blood vessels. Lubrizol links these laboratory results to the under-eye area. We could not find the underlying data, so the claim cannot be checked.
One independent laboratory study gives a partial clue. Wu and colleagues picked a test level for each peptide from a single readout. For acetyl tetrapeptide-5, that readout was “angiotensin-converting enzyme 1 activity” (Wu et al., 2021). The abstract does not report the size of that effect or say how the assay was run.
What is acetyl tetrapeptide-5 used for?
CosIng lists one cosmetic function for acetyl tetrapeptide-5: humectant. A humectant helps a product hold water. The CosIng record links no annex of the EU Cosmetics Regulation and no scientific committee opinion to this ingredient.
Lubrizol markets Eyeseryl for the skin under the eyes. A 2026 review of cosmetic peptide safety lists acetyl tetrapeptide-5 in its table of peptide classes used in cosmetics (Bjerke et al., 2026). For how this fits among other cosmetic peptides, see our peptides in skincare overview.
What does the research show?
Wu 2021 (in vitro). This study used human skin fibroblasts pushed into early aging with hydrogen peroxide. It tested five cosmetic peptides alone and in mixtures: carnosine, GHK, acetyl tetrapeptide-5, hexapeptide-11 and acetyl hexapeptide-3. One mixture contained carnosine, acetyl tetrapeptide-5, hexapeptide-11 and acetyl hexapeptide-3.
That mixture lowered two markers of oxidative damage, malondialdehyde and hydroxyl radicals. It raised hydroxyproline, elastin, and the antioxidant enzymes SOD and glutathione peroxidase. The abstract gives no numbers. The authors are from Chinese universities and research institutes (Wu et al., 2021). Because the peptides were combined, the result does not isolate acetyl tetrapeptide-5.
Manufacturer claims. Lubrizol reports “improved skin luminance and reduced darkness under the eyes after 14 days.” It also claims “up to 27% reduction in the volume of eyebags in men” (Lubrizol). We found no peer-reviewed report of these tests, their size or their controls.
We found no peer-reviewed human study that tested acetyl tetrapeptide-5 on its own.
What safety data exist?
We found no Cosmetic Ingredient Review (CIR) safety assessment for acetyl tetrapeptide-5. CIR’s quick reference table, September 2020 edition, does not list it (CIR, 2020). Searches of the CIR website and PubMed found no later report. CosIng links no opinion from the EU Scientific Committee on Consumer Safety (SCCS).
No published human safety data specific to acetyl tetrapeptide-5 turned up in our searches. Five of the six authors of the 2026 review work for Procter & Gamble. They argue that safety review of cosmetic peptides “must also evolve” and propose computer-based screens for toxin-like or allergen-like sequences (Bjerke et al., 2026).
What is acetyl tetrapeptide-5’s regulatory status, and how is it used in research?
Acetyl tetrapeptide-5 is a cosmetic ingredient, not an FDA-approved drug. FDA states that cosmetic products and ingredients, except color additives, “do not need FDA premarket approval” (FDA, 2025). The law defines cosmetics by intended use, such as “beautifying, promoting attractiveness, or altering the appearance.” Products meant to treat or prevent disease are drugs (FDA, 2024).
Congress enacted the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) on December 29, 2022 (FDA, 2026). It requires facility registration, product listing, serious adverse event reports within 15 business days, and safety records (FDA MoCRA page). In the EU, CosIng lists acetyl tetrapeptide-5 as an active entry.
In published research, acetyl tetrapeptide-5 appears mainly in laboratory screens of cosmetic peptides, such as the Wu fibroblast study.
Frequently asked questions about acetyl tetrapeptide-5
Is acetyl tetrapeptide-5 the same as Eyeseryl?
Eyeseryl is Lubrizol’s trade name for an ingredient solution whose INCI listing includes acetyl tetrapeptide-5. PubChem also lists Eyeseryl as a synonym.
Is acetyl tetrapeptide-5 a peptide?
Yes. It is four units joined by peptide bonds: beta-alanine, histidine, serine and histidine, with an acetyl group at the start.
Is acetyl tetrapeptide-5 related to carnosine?
Its first two units, beta-alanine and histidine, are the same pair that makes up carnosine. The two are different molecules.
Is acetyl tetrapeptide-5 FDA-approved?
No. It is a cosmetic ingredient. US cosmetic ingredients, other than color additives, do not need FDA premarket approval.
Is there independent evidence for the eye-bag claims?
Not that we found. The figures come from the manufacturer, and we found no peer-reviewed report of the tests.
What to know now
- Identity: INCI name acetyl tetrapeptide-5; trade name Eyeseryl; Ac-β-Ala-His-Ser-His; 492.5 g/mol.
- CosIng function: humectant.
- Mechanism: manufacturer reports anti-glycation and vessel-permeability effects in vitro; not independently published.
- Evidence: one independent cell study, in a peptide mixture; no peer-reviewed human study of it alone.
- Safety: no CIR or SCCS assessment found.
- Status: cosmetic ingredient; not an FDA-approved drug.
What we’re watching
FDA’s ongoing MoCRA rollout, tracked on its MoCRA page, last updated October 29, 2026. Any CIR review of acetyl tetrapeptide-5, which would appear on cir-safety.org. Related guides: carnosine, acetyl octapeptide-3 and Argireline.